1) The cells that display peptides associated with class II MHC molecules to CD4+ Th cells are called antigen presentation cells.
Which of the following is not a professional antigen-presenting cells?
a) Dendritic cells
b) Macrophages
c) B cells
d) Fibroblast
2) The professional antigen-presenting cells have different antigen uptake, constitutive MHC expression, and co-stimulatory activity.
a) Dendritic cells
b) Macrophages
c) B cells
d) Fibroblast
2) The professional antigen-presenting cells have different antigen uptake, constitutive MHC expression, and co-stimulatory activity.
Which of the following statement is true?
a) Dendritic cells constitutively express a high level of class II MHC molecules and co-stimulatory activity, they can activate naïve T cells.
b) Macrophage must be activated by phagocytosis of particular antigens before they express class II MHC molecules or co-stimulatory B-47 membrane molecules
c) B cells constitutively express class II MHC molecules but must be activated before they express the co-stimulatory signal
d) All of the Above
3) The antigenic peptide derived by class I are derived from the endogenous processing pathway.
a) Dendritic cells constitutively express a high level of class II MHC molecules and co-stimulatory activity, they can activate naïve T cells.
b) Macrophage must be activated by phagocytosis of particular antigens before they express class II MHC molecules or co-stimulatory B-47 membrane molecules
c) B cells constitutively express class II MHC molecules but must be activated before they express the co-stimulatory signal
d) All of the Above
3) The antigenic peptide derived by class I are derived from the endogenous processing pathway.
The researcher performed exposure of different antigens and obtained the following results.
Emetine is a protein synthesis inhibitor and Chloroquine inhibits the endocytosis pathway.
Exposure
Condition
|
MHC I restricted
T-cell activation
|
Infectious Virus
|
+
|
Inactivated
Non-infectious virus
|
-
|
Infectious virus
+ Emetine
|
-
|
Infectious virus
+ Cholorquine
|
+
|
Which of the following options is the correct answer?
a) MHC class I antigen presentation requires active infectious virus
b) The viral protein synthesis is required for MHC-Class I- peptide presentation
c) The endocytic pathway is not required for MHC-class I restricted activation
d) All of the above
4) The peptides for presentation on MHC-I are generated by a protease complex called the proteasome.
a) The peptides are targeted for proteolysis with the attachment of ubiquitin
b) Ubiquitin-protein conjugate are recognized and degraded by a complex called proteasome
c) The proteasome-mediated proteolysis is ATP dependent
d) All of the above
5) The antigenic peptide derived by class II is derived from the exogenous processing pathway.
a) MHC class I antigen presentation requires active infectious virus
b) The viral protein synthesis is required for MHC-Class I- peptide presentation
c) The endocytic pathway is not required for MHC-class I restricted activation
d) All of the above
4) The peptides for presentation on MHC-I are generated by a protease complex called the proteasome.
a) The peptides are targeted for proteolysis with the attachment of ubiquitin
b) Ubiquitin-protein conjugate are recognized and degraded by a complex called proteasome
c) The proteasome-mediated proteolysis is ATP dependent
d) All of the above
5) The antigenic peptide derived by class II is derived from the exogenous processing pathway.
The researcher performed exposure of different antigens and obtained the following results.
Emetine is a protein synthesis inhibitor and Chloroquine inhibits the endocytosis pathway.
Exposure Condition |
MHC II-restricted T-cell activation
|
Infectious Virus
|
+
|
Inactivated Non-infectious virus
|
+
|
Infectious virus + Emetine
|
+
|
Infectious virus + Chloroquine
|
-
|
Which of the following options is the correct answer?
a) MHC class II presentation does not require active virus
b) The endogenous viral protein synthesis is not required for MHC-II peptide presentation
c) Inhibition of endocytic pathway hinders MHC class II-restricted T cell activation
d) None of the above
6) Transporter associated with antigen processing (TAP) is involved in the transport of the antigenic peptide from the cytosol to the endoplasmic reticulum.
b) The endogenous viral protein synthesis is not required for MHC-II peptide presentation
c) Inhibition of endocytic pathway hinders MHC class II-restricted T cell activation
d) None of the above
6) Transporter associated with antigen processing (TAP) is involved in the transport of the antigenic peptide from the cytosol to the endoplasmic reticulum.
Which of the following is the correct answer?
a) TAP 1 & TAP 2 are class of ABC binding cassette proteins required for transport of processed peptides and they are highly polymorphic
b) TAP has the highest affinity for a peptide containing 8-10 amino acids and favors hydrophobic amino acids
c) Define mutation of TAP proteins lead to immunodeficiency and autoimmunity
d) All of the above
7) The chaperone is associated with free class Iα chain facilitate its folding and release after binding to β2 macroglobulin is.........................................
a) Calnexin
b) Calreticulin
c) Tapasin
d) Ubiquitin
8) Which of the following chaperones are bound to MHC class Iα chain and β2 microglobulin and facilitate the formation of MHC- class Iα, β2 microglobulin, and antigenic peptide trimers?
a) Calnexin & Calreticulin
b) Calreticulin & Tapasin
c) Calnexin & Tapasin
d) Calnexin & Ubiquitin
9) Which of the following mechanism is involved in the internalization of antigen by B cells?
a) Pinocytosis
b) Phagocytosis
c) Receptor-mediated endocytosis
d) All the above
a) TAP 1 & TAP 2 are class of ABC binding cassette proteins required for transport of processed peptides and they are highly polymorphic
b) TAP has the highest affinity for a peptide containing 8-10 amino acids and favors hydrophobic amino acids
c) Define mutation of TAP proteins lead to immunodeficiency and autoimmunity
d) All of the above
7) The chaperone is associated with free class Iα chain facilitate its folding and release after binding to β2 macroglobulin is.........................................
a) Calnexin
b) Calreticulin
c) Tapasin
d) Ubiquitin
8) Which of the following chaperones are bound to MHC class Iα chain and β2 microglobulin and facilitate the formation of MHC- class Iα, β2 microglobulin, and antigenic peptide trimers?
a) Calnexin & Calreticulin
b) Calreticulin & Tapasin
c) Calnexin & Tapasin
d) Calnexin & Ubiquitin
9) Which of the following mechanism is involved in the internalization of antigen by B cells?
a) Pinocytosis
b) Phagocytosis
c) Receptor-mediated endocytosis
d) All the above
10) Chloroquine is an inhibitor of endocytic processing which...........................................................
a) increases the pH of lysosome and inactivation of lysosomal proteases
b) allosterically inhibit lysosomal proteases
c) inhibits peptide uptake into cells
d) None of the above
11) Before loading an antigenic peptide, MHC molecules exist in.......................................................
a) monomers of α and β chain
b) dimers with an empty peptide-binding site
c) Trimers with peptide binding site with class II-associated invariant peptide
d) None of the above
12) Which of the following non-classical MHC molecule is required for the catalysis of exchange of CLIP peptide with antigenic peptide?
a) HLA-DI
b) HLA- DM
c) HLA-DQ
d) HLA-DO
13) Which of the following non-classical MHC molecule impede the exchange of CLIP peptide with antigenic peptide?
HLA-DI
HLA-DM
HLA-DQ
HLA-DO
a) increases the pH of lysosome and inactivation of lysosomal proteases
b) allosterically inhibit lysosomal proteases
c) inhibits peptide uptake into cells
d) None of the above
11) Before loading an antigenic peptide, MHC molecules exist in.......................................................
a) monomers of α and β chain
b) dimers with an empty peptide-binding site
c) Trimers with peptide binding site with class II-associated invariant peptide
d) None of the above
12) Which of the following non-classical MHC molecule is required for the catalysis of exchange of CLIP peptide with antigenic peptide?
a) HLA-DI
b) HLA- DM
c) HLA-DQ
d) HLA-DO
13) Which of the following non-classical MHC molecule impede the exchange of CLIP peptide with antigenic peptide?
HLA-DI
HLA-DM
HLA-DQ
HLA-DO
14) Which of the following is not the characteristic feature of HLA DM?
a) The HLA-DM is widely conserved among mammalian species
b) HLA is not polymorphic
c) HLA DM is present in the endosome
d) HLA is present in the cell surface
15) In B cell, the receptor that mediates the endocytosis of antigen is called........................................
a) Membrane-bound antibody
b) MHC-II molecule
c) CD41 antigen
d) CD20 antigen
16) The fate of the B-cell receptor that mediates antigen endocytosis is known as......................................................
a) The antigen is endocytosed and the receptor remains at the surface
b) Both antigen and receptor are endocytosed but the receptor is recycled to the cell surface
c) Both antigen and receptor, processed and degraded
d) None of the above
17) Which of the following is true for the antigenic peptide that is presented via MHC class I and MHC class II?
a) They are non-covalently but stably bound to MHC
b) They are covalently bound to the MHC
c) The antigen peptide dissociate from MHC once it reaches the cell surface
d) The antigen can be replaced by other peptides on the cell membrane
18) The properties of CD1, a non-classical pathway for antigen presentation is
a) Similar to MHC class I, CD1 interacts with β2 microglobulin
b) The genes are located in chromosome 1
c) The antigen-binding site for CD1 is deeper and more voluminous
d) All of the above
19) CD1 is mainly involved in the presentation of ……………………...... and activation of T cells
a) Peptides
b) Lipopolysaccharides
c) Both
d) None
a) The HLA-DM is widely conserved among mammalian species
b) HLA is not polymorphic
c) HLA DM is present in the endosome
d) HLA is present in the cell surface
15) In B cell, the receptor that mediates the endocytosis of antigen is called........................................
a) Membrane-bound antibody
b) MHC-II molecule
c) CD41 antigen
d) CD20 antigen
16) The fate of the B-cell receptor that mediates antigen endocytosis is known as......................................................
a) The antigen is endocytosed and the receptor remains at the surface
b) Both antigen and receptor are endocytosed but the receptor is recycled to the cell surface
c) Both antigen and receptor, processed and degraded
d) None of the above
17) Which of the following is true for the antigenic peptide that is presented via MHC class I and MHC class II?
a) They are non-covalently but stably bound to MHC
b) They are covalently bound to the MHC
c) The antigen peptide dissociate from MHC once it reaches the cell surface
d) The antigen can be replaced by other peptides on the cell membrane
18) The properties of CD1, a non-classical pathway for antigen presentation is
a) Similar to MHC class I, CD1 interacts with β2 microglobulin
b) The genes are located in chromosome 1
c) The antigen-binding site for CD1 is deeper and more voluminous
d) All of the above
19) CD1 is mainly involved in the presentation of ……………………...... and activation of T cells
a) Peptides
b) Lipopolysaccharides
c) Both
d) None
20) What is the characteristic feature of TAP deficiency?
a) Increased NK cells
b) Increased CD8+ T cells
c) Increased MHC class I expression cell surface
d) None of the above
a) Increased NK cells
b) Increased CD8+ T cells
c) Increased MHC class I expression cell surface
d) None of the above
Multiple Choice Answers Review:
1-d) Fibroblast
2-b) Macrophage must be activated by phagocytosis of particular antigens before they express class II MHC molecules or co-stimulatory B-47 membrane molecules
3-c) The endocytic pathway is not required for MHC-class I restricted activation
4- d) All of the above
5- d) None of the above
6-d) All of the above
7-a) Calnexin
8-b) Calreticulin & Tapasin
9-c) Receptor-mediated endocytosis
10-a) increases the pH of lysosome and inactivation of lysosomal proteases
11-c) Trimers with peptide binding site with class II-associated invariant peptide
12-b) HLA- DM
13- c) HLA-DQ
14- d) HLA is present in the cell surface
15-a) Membrane-bound antibody
16-b) Both antigen and receptor are endocytosed but the receptor is recycled to the cell surface
17- a) They are non-covalently but stably bound to MHC
18-d) All of the above
19-b) Lipopolysaccharides
20-a) Increased NK cells
2-b) Macrophage must be activated by phagocytosis of particular antigens before they express class II MHC molecules or co-stimulatory B-47 membrane molecules
3-c) The endocytic pathway is not required for MHC-class I restricted activation
4- d) All of the above
5- d) None of the above
6-d) All of the above
7-a) Calnexin
8-b) Calreticulin & Tapasin
9-c) Receptor-mediated endocytosis
10-a) increases the pH of lysosome and inactivation of lysosomal proteases
11-c) Trimers with peptide binding site with class II-associated invariant peptide
12-b) HLA- DM
13- c) HLA-DQ
14- d) HLA is present in the cell surface
15-a) Membrane-bound antibody
16-b) Both antigen and receptor are endocytosed but the receptor is recycled to the cell surface
17- a) They are non-covalently but stably bound to MHC
18-d) All of the above
19-b) Lipopolysaccharides
20-a) Increased NK cells
Thank you for sharing superb information. Your website is so cool. I’m impressed by the info that you have on this blog. It reveals how nicely you perceive this subject. Bookmarked this web page, will come back for more articles. buy ghrp 2 peptides
ReplyDeleteThanks For Sharing This Post With Us.
ReplyDelete